Insight Molecular Diagnostics Inc. Common Stock IMDX Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $28.2M-9.1% | $11.58M+34.1% | $18.69M+456% | $24.29M+162% | $31.03M+456% | ||
| $729K-57.1% | $729K— | $729K-57.1% | $1.7M0.0% | $1.7M0.0% | ||
| $157K-95.6% | $1.13M-30.1% | $258K+23.4% | $512K+502% | $3.54M+2,099% | ||
| $382K-16.8% | $446K+8.8% | $471K+103% | $693K— | $459K— | ||
| $1.05M-15.1% | $1.42M+73.0% | $1.24M+97.6% | $1.35M+127% | $1.24M+68.0% | ||
| $30.52M-15.8% | $15.31M+30.2% | $21.39M+346% | $26.84M+169% | $36.26M+455% | ||
| $574K-10.6% | $593K-14.2% | $672K-3.9% | $702K+24.7% | $642K+46.6% | ||
| $40.43M-33.0% | $25.76M-26.6% | $43.94M-37.4% | $50.52M-32.4% | $60.36M-15.0% | ||
| $1.62M-29.1% | $2.54M+55.0% | $1.06M+21.1% | $1.28M+21.5% | $2.28M+151% | ||
| $2.74M+8.4% | $2.78M+336% | $2.23M+16.9% | $1.46M+11.5% | $2.52M+4.0% | ||
| $12.01M+24.0% | $12.08M+66.0% | $7.66M-15.7% | $6.65M-7.6% | $9.68M+16.3% | ||
| $917K-1.0% | $1.06M+13.4% | $996K-2.1% | $1.01M+105% | $926K— | ||
| $1.97M-18.2% | $2.26M-14.0% | $1.95M-31.1% | $2.19M-28.0% | $2.41M— | ||
| $51.12M+1.9% | $57.22M+20.8% | $53.13M-12.2% | $49.42M-5.0% | $50.14M-7.2% | ||
| $0— | $0— | —— | —— | —— | ||
| $394.29M+7.3% | $369.21M+9.2% | $368.52M+60.2% | $367.97M+60.0% | $367.39M+59.7% | ||
| -$405.05M-13.4% | -$400.76M-14.3% | -$377.81M-19.2% | -$366.95M-20.9% | -$357.21M-19.5% | ||
| $71K+73.2% | $86K+310% | $86K+50.9% | $85K+130% | $41K+2.5% | ||
| -$10.69M-205% | -$31.46M-156% | -$9.2M-195% | $1.1M-95.2% | $10.22M-11.8% | ||
| $40.43M-33.0% | $25.76M-26.6% | $43.94M-37.4% | $50.52M-32.4% | $60.36M-15.0% | ||
| $574K-10.6% | $593K-14.2% | $672K-3.9% | $702K+24.7% | $642K+46.6% | ||
| $6.45M— | $6.44M+80.4% | $4.15M— | $4.15M— | —— | ||
| $2.46M— | $2.82M+2.1% | —— | —— | —— | ||
| $574K-10.6% | $593K-14.2% | $672K-3.9% | $702K+24.7% | $642K+46.6% | ||
| $574K-10.6% | $593K-14.2% | $672K-3.9% | $702K+24.7% | $642K+46.6% | ||
| $1.28M-33.4% | $939K+125% | $602K-38.9% | $571K+50.7% | $1.93M+160% | ||
| $1.12M0.0% | $1.12M0.0% | $1.12M+0.4% | $1.12M0.0% | $1.12M0.0% | ||
| $3.33M+32.1% | $2.46M+26.9% | $2.23M+16.9% | $1.46M+11.5% | $2.52M+4.0% | ||
| $3.33M+32.1% | $2.46M+26.9% | $2.23M+16.9% | $1.46M+11.5% | $2.52M+4.0% | ||
| $1.76M— | $1.81M+39.5% | —— | —— | —— | ||
| $2.74M— | $2.78M+336% | —— | —— | —— | ||
| $37.81M-1.5% | $43.46M+15.2% | $43.94M-9.8% | $40.93M-3.0% | $38.39M-11.2% | ||
| $2.89M-13.5% | $3.32M-6.8% | $2.95M-23.4% | $3.2M-9.4% | $3.34M— | ||
| $394.29M+7.3% | $369.21M+9.2% | $368.52M+12.8% | $367.97M+12.8% | $367.39M+18.3% | ||
| $0— | $0— | —— | —— | —— | ||
| $1.12M0.0% | $1.12M0.0% | $1.12M+0.4% | $1.12M0.0% | $1.12M0.0% | ||
| $1.31M— | $1.69M-28.7% | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Insight Molecular Diagnostics Inc. Common Stock's total assets?
- Insight Molecular Diagnostics Inc. Common Stock (IMDX) holds $40.4M in total assets, down 33.0% year over year.
- How much debt does Insight Molecular Diagnostics Inc. Common Stock have?
- Insight Molecular Diagnostics Inc. Common Stock carries $2.9M in total debt against -$10.7M of shareholders' equity, a debt-to-equity ratio of 2.91.
- How much cash does Insight Molecular Diagnostics Inc. Common Stock have?
- Insight Molecular Diagnostics Inc. Common Stock holds $28.2M in cash and equivalents.
- Can Insight Molecular Diagnostics Inc. Common Stock cover its short-term obligations?
- Its current ratio is 2.54 — current assets exceed current liabilities.
- Where does Insight Molecular Diagnostics Inc. Common Stock's balance sheet data come from?
- Every line is extracted from Insight Molecular Diagnostics Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
